Young Innovations has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life science industries.
Under the terms of the agreement, holders of outstanding shares of common stock of Young will receive $39.50 per share, representing a 12.5% premium to the 30-day average closing stock price, making the deal worth about $313 million.
The agreement was unanimously approved by Young's board of directors, according to a company press release.
A special meeting of Young's shareholders will be held after the preparation and filing of a proxy statement with the Securities and Exchange Commission and subsequent mailing to shareholders. If the merger is approved by shareholders, the transaction is expected to close in the first quarter of the 2013 calendar year.
Upon completion of the acquisition, Young will become a private company, wholly owned by an affiliate of Linden.
Young is permitted to solicit alternative acquisition proposals from third parties through January 12, 2013, and intends to consider any such proposals, the company noted.
Young develops, manufactures, and markets a broad range of dental supplies and equipment, including disposable and metal prophy angles, prophy cups and brushes, dental microapplicators, moisture control products, infection control products, dental handpieces and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. The company also offers a line of diagnostic products that includes panoramic x-ray machines and related supplies.
